There were 1,334 press releases posted in the last 24 hours and 447,071 in the last 365 days.

The global biochips market was valued at $9,037 million in 2017, and is projected to reach $21,419 million by 2025 at a CAGR of 11.2% from 2018 to 2025

Biochips Market by Product (DNA Chip, Protein Chip, Lab-on-a-chip, and Others), Application (Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture, and Others), and End User (Biotechnology & Pharmaceutical Companies, Hospitals & Diagnostics Centers, Academic & Research Institutes, and Others): Global Opportunity Analysis and Industry Forecast, 2018 - 2025

New York, Nov. 18, 2019 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Biochips Market by Product, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2018 - 2025" - https://www.reportlinker.com/p05663899/?utm_source=GNW

Biochips Market Overview :

Biochip is a miniaturized medical device, which performs several biochemical reactions. This device is a collection of microarrays or micro-test strips that are arranged on the surface of chip, and are meant to perform multiple tests simultaneously. Biochip is extremely small in size ranging from 2 inches to 12 inches. These chips can perform various biotechnology applications such as decoding genes and searching for contaminations in the sample in a few seconds.

The global biochips market was valued at $9,037 million in 2017, and is projected to reach $21,419 million by 2025 at a CAGR of 11.2% from 2018 to 2025. Factors such as rise in prevalence of various life-threatening diseases increases the demand for disease diagnostics, which in turn drives the growth of the global biochips market. Moreover, rise in adoption of personalized medicines and presence of large geriatric population boost the market growth. However, lack of knowledge related to biochips and their high cost of hamper the market growth. Conversely, huge untapped potential in the emerging countries, such as China and India, and rise in R&D investment as well as government funding are expected to offer lucrative opportunities to the market players.

The global biochips market is segmented based on product, application, end user, and region. Depending on product, the market is divided into DNA chip, protein chip, lab-on-a-chip, and others. By application, it is categorized into drug discovery & development, disease diagnostics, genomics, proteomics, agriculture, and other applications. On the basis of end user, it is classified into biotechnology & pharmaceutical companies, hospitals & diagnostics centers, academic & research institutes, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Benefits for Biochips Market :

The study provides an in-depth analysis of the global biochips market along with current trends and future estimations from 2018 to 2025 to elucidate the imminent investment pockets.

Comprehensive analysis of factors that drive and restrict the market growth is provided.

Identification of factors instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market on a global & regional scale are provided.

Key players are profiled, and their strategies are analyzed thoroughly to understand the competitive outlook of the market.

Biochips Key market segments :

By Product
DNA Chip

Protein Chip

Lab-on-a-chip

Others

By Application
Drug Discovery & Development

Disease Diagnostics

Genomics

Proteomics

Agriculture

Others

By End User
Biotechnology & Pharmaceutical Companies

Hospitals & Diagnostics Centers

Academic & Research Institutes

Others

By Region
North America

U.S.

Canada

Mexico

Europe

Germany

France

UK

Italy

Spain

Rest of Europe

Asia-Pacific

Japan

China

India

Australia

South Korea

Rest of Asia-Pacific

LAMEA

Brazil

Saudi Arabia

South Africa

Rest of LAMEA

LIST OF KEY PLAYERS PROFILED IN THE REPORT
bioMérieux SA

Bio-Rad Laboratories, Inc.

F. Hoffmann-La Roche AG

Fluidigm Corporation

HORIBA, Ltd.

Illumina, Inc.

PerkinElmer, Inc.

QIAGEN N.V.

Randox Laboratories Ltd.

Thermo Fisher Scientific Inc.

LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request.)
Micronit Microfluidics BV

OriGene Technologies, Inc.

ANALIS sa/nv

AMS Alliance

Dynamic Biosensors GmbH
Read the full report: https://www.reportlinker.com/p05663899/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.